News | July 02, 2024
Merck and Orion announce option providing Merck global exclusive rights to Opevesostat
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
Laurus Labs receives EIR from USFDA for API facilities
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
